Trulieve Cannabis (TRLV)
Vertically integrated medical-cannabis cultivator, manufacturer, and dispensary operator.
Something off on this page? Send us feedback.
Produces medical-cannabis flower, extracts, and finished products, earning most revenue through branded dispensaries while also serving selected wholesale channels. Its vertically integrated, medical-only operation spans Florida, Pennsylvania, West Virginia, and Georgia.
Operates a vertically integrated medical-cannabis business that cultivates, processes, and manufactures cannabis products, then sells them primarily through branded dispensaries. Its portfolio spans flower, extracts, and finished products across premium, core, and value labels, with online reservations, a mobile app, and a rewards program extending the retail channel.
Runs a medical-only consolidated footprint across Florida, Pennsylvania, West Virginia, and Georgia, with Florida and Pennsylvania as cornerstone markets. Cultivation, production, retail, and selective wholesale are organized through Southeast and Northeast hubs; Georgia also supplies approved products to independent pharmacies. Maintaining state licenses and federal DEA registrations is essential, while most retail footprint is in Florida.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $325.4M · Total debt $577.3M · Total assets $2.08B · Shareholders' equity $767.5M
- Revenue
- $271.0M
- Operating income
- −$370.5M
- Net income
- −$406.1M
No dividends on record.
192.57M company shares as of Sep 23, 2026 · holders as of their latest filing
Two share counts disagree (192.57M in the company's Sep 23, 2026 report, 169.90M elsewhere); stakes use the report.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
AdvisorShares TrustInstitution | 5.53% | 10.64M | filed Jul 8, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Colgate-Palmolive
Florida medical retail and Pennsylvania branded-cannabis competitor.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Trulieve Cannabis | $12.49 | +0.16% | $2.12B | — | 27.1 | 1.9 | −10.3% |
| Colgate-Palmolive | $86.33 | −0.83% | $69.66B | 34.5 | 22.0 | 3.3 | +4.9% |
| Median | 34.5 | 22.0 | 3.3 | +4.9% |